Fresenius Medical Care AG/€FME
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care AG
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
Ticker
€FME
Sector
Primary listing
XETRA
Employees
112,445
Headquarters
Website
FME Metrics
BasicAdvanced
€12B
17.01
€2.44
-
€1.44
3.47%
Price and volume
Market cap
€12B
52-week high
€54.02
52-week low
€39.43
Average daily volume
18K
Dividend rate
€1.44
Financial strength
Current ratio
1.359
Quick ratio
0.787
Long term debt to equity
67.12
Total debt to equity
75.297
Dividend payout ratio (TTM)
58.83%
Interest coverage (TTM)
4.15%
Profitability
EBITDA (TTM)
2,271.017
Gross margin (TTM)
25.00%
Net profit margin (TTM)
3.66%
Operating margin (TTM)
8.16%
Effective tax rate (TTM)
23.29%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on assets (TTM)
3.16%
Return on equity (TTM)
6.32%
Valuation
Price to earnings (TTM)
17.013
Price to revenue (TTM)
0.621
Price to book
0.93
Price to tangible book (TTM)
-6.36
Price to free cash flow (TTM)
6.896
Free cash flow yield (TTM)
14.50%
Free cash flow per share (TTM)
6.018
Dividend yield (TTM)
3.47%
Forward dividend yield
3.47%
Growth
Revenue change (TTM)
2.10%
Earnings per share change (TTM)
8.40%
3-year revenue growth (CAGR)
1.03%
10-year revenue growth (CAGR)
3.01%
3-year earnings per share growth (CAGR)
-2.10%
10-year earnings per share growth (CAGR)
-1.82%
3-year dividend per share growth (CAGR)
2.17%
10-year dividend per share growth (CAGR)
5.99%
What the Analysts think about FME
Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.
Bulls say / Bears say
At its Capital Markets Day on June 17, 2025, Fresenius Medical Care announced a €1 billion share buyback, pledged a 30–40% dividend payout, and set long-term goals including a mid-teens operating margin by 2030, underlining its strong commitment to shareholder returns.
In Q2 2025, the company achieved 7% organic revenue growth and a 23% rise in net profit at constant currency, exceeded analysts’ revenue forecasts, reiterated its full-year guidance, and launched the initial phase of its €1 billion buyback.
Fresenius Medical Care beat Q1 2025 estimates with €4.88 billion in revenue compared to the €4.85 billion consensus, and €457 million in adjusted operating income versus the €446 million expected, showing solid performance in a tough environment.
Q2 2025 results showed increased patient outflow and more missed treatments than anticipated after a severe flu season, signaling ongoing volume headwinds despite solid referral trends.
In Q1 2025, U.S. same market treatments were unchanged and total dialysis days dropped due to a spike in flu and cold cases in February, highlighting how vulnerable the company remains to seasonal health challenges in its core market.
Following the June 17, 2025 announcement of a €1 billion share buyback, Fresenius Medical Care’s shares fell about 2%, indicating investors have doubts about the company’s growth outlook.
Data summarised monthly by Lightyear AI. Last updated on 31 Oct 2025.
FME Financial Performance
Revenues and expenses
FME Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fresenius Medical Care AG stock?
Fresenius Medical Care AG (FME) has a market cap of €12B as of November 09, 2025.
What is the P/E ratio for Fresenius Medical Care AG stock?
The price to earnings (P/E) ratio for Fresenius Medical Care AG (FME) stock is 17.01 as of November 09, 2025.
Does Fresenius Medical Care AG stock pay dividends?
Yes, the Fresenius Medical Care AG (FME) stock pays dividends to shareholders. As of November 09, 2025, the dividend rate is €1.44 and the yield is 3.47%. Fresenius Medical Care AG has a payout ratio of 58.83% on a trailing twelve-month basis.
When is the next Fresenius Medical Care AG dividend payment date?
The next Fresenius Medical Care AG (FME) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius Medical Care AG?
Fresenius Medical Care AG (FME) does not currently have a Beta indicator.